JD

Jenish Dipakbhai Vaghasiya

Active Director Director DIN 11205896
DIN 11205896 First appointment Jul 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Jenish Dipakbhai Vaghasiya

Data last updated:

Jenish Dipakbhai Vaghasiya is a Director at Sellco Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11205896
Primary Designation Director
Industry Pharma
First Appointment 22 Jul 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Jul 20252025Active

Board colleagues of Jenish Dipakbhai Vaghasiya

Directorship timeline

Open interactive timeline →
Sellco Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jenish Dipakbhai Vaghasiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jenish Dipakbhai Vaghasiya

Jenish Dipakbhai Vaghasiya currently holds 1 directorship: Sellco Pharmaceuticals Private Limited (Director, since 22 Jul 2025).

Jenish Dipakbhai Vaghasiya was first appointed on 22 Jul 2025 as Director at Sellco Pharmaceuticals Private Limited.

The current boards of Jenish Dipakbhai Vaghasiya's companies include Akshay Bhagvanjibhai Hirapara (Sellco Pharmaceuticals Private Limited), Krushita Kishorbhai Babariya (Sellco Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available